Upon angiotensin II (Ang II) infusion, both Tet2- and Dnmt3a-mutant mice exhibited exacerbated cardiac hypertrophy, impaired cardiac function, and increased cardiac and renal fibrosis, reinforcing the role of CHIP in cardiovascular dysfunction [54]. Here, AGT is linked to cardiac hypertrophy.